Ruihe Capital
Signal active
Investment Firm
Overview
Ruihe Capital is an investment firm.
Highlights
Founded
2010
Industry
Employees
0
Investment
30
Lead Investment
1
Exits
2
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Ruihe Capital, established in 2010 and headquartered in Asia., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Pharmaceutical, Venture Capital, Finance, Biotechnology, Medical, Financial Services, Asset Management, Consulting, Biopharma, Medical Device. The organization boasts a portfolio of 29 investments, with an average round size of $17.8M and 2 successful exits. Their recent investments include Leming Pharmaceuticals, Sinopharm-CICC, Fuho Capital, Huaxian Pharmaceutical, TopoScend Capital. The highest investment round they participated in was $7.8B. Among their most notable exits are Leming Pharmaceuticals and Sinopharm-CICC. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Ruihe Capital has made 30 investments. Their most recent investment was on Jun 07, 2024, when Leming Pharmaceuticals raised $13.8M.
investments
30
Diversity investments
0
Lead investments
1
Number of exits
2
Investments
30
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Nov 03, 2023 | Nalinway Nano Technology | Advanced Materials | 13.7M |
| Nov 06, 2023 | AffectOR MedTech | Health Care | null |
| May 11, 2024 | Xinyue | Information Technology | 1.4M |
| Jun 07, 2024 | Leming Pharmaceuticals | Pharmaceutical | 13.8M |
Exits
2
Funding Timeline
Funding rounds
30
Investors
0
Funds
0
Funding Rounds
30
Ruihe Capital has raised 30 rounds. Their latest funding was raised on Jun 07, 2024 from a Venture Round - Leming Pharmaceuticals round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Nov 03, 2023 | Series D - Nalinway Nano Technology | - | 13.7M | - |
| Nov 06, 2023 | Seed Round - AffectOR MedTech | - | 0 | - |
| May 11, 2024 | Series A - Xinyue | - | 1.4M | - |
| Jun 07, 2024 | Venture Round - Leming Pharmaceuticals | - | 13.8M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.